September 4, 2024 Maria Dranishnikova Less-lethal weapons maker Byrna preliminarily reports 200% revenue growth, stock soars
September 4, 2024 Maria Dranishnikova Haypp could lose 20% of sales in Stockholm city crackdown on snus
September 3, 2024 Maria Dranishnikova Barchart.com contributor fingers small AI company with 79% upside
September 3, 2024 Maria Dranishnikova Insider Monkey names seven AI penny stocks most popular with hedge funds
September 2, 2024 Maria Dranishnikova Zacks spotlights cancer and sepsis test developer VolitionRx as undervalued
August 30, 2024 Maria Dranishnikova Value of company developing kidney disease treatments doubles in one day
August 29, 2024 Maria Dranishnikova Small caps and the U.S. election: How investors can win in the home stretch
August 29, 2024 Maria Dranishnikova Byrna shares rise after Uruguay buys its less-lethal launchers, ammunition
August 28, 2024 Maria Dranishnikova Pharmaceutical company Sonoma slides after reverse stock split announced
August 27, 2024 Maria Dranishnikova Vaping addiction treatment developer changes CEO, possibly ahead of sale
August 27, 2024 Maria Dranishnikova Simply Wall St recommends three dividend stocks for investors seeking stability
August 26, 2024 Maria Dranishnikova Stock of Asian food company DDC jumps after loan restructuring announced
August 23, 2024 Maria Dranishnikova Benzinga spotlights three small-cap stocks that have doubled in 2024
August 23, 2024 Maria Dranishnikova Small caps outperform large caps in election years — Royce Investment Partners
August 22, 2024 Maria Dranishnikova How to build a company in the pharmaceutical industry: Three principles of small-cap Citius Pharma
August 22, 2024 Maria Dranishnikova Simply Wall St spotlights three small stocks with ‘strong potential’
August 21, 2024 Maria Dranishnikova Low-cost power acquisition expected to add $1 million in annual revenue for Bitcoin miner Gryphon
August 20, 2024 Maria Dranishnikova Shares of small diagnostics companies soar amid spread of monkeypox
August 20, 2024 Maria Dranishnikova Lexaria on track to reduce production costs for Novo Nordisk’s diabetes drug
August 20, 2024 Yevgeniya Vatamaniuk Shares of monkeypox treatment maker GeoVax surge 50% amid news flow
August 19, 2024 Maria Dranishnikova The Motley Fool spotlights three small caps to buy ahead of expected Fed rate cuts